TrialPharmaceutical research2013

Exploration of optimal dosing regimens of haloperidol, a D2 Antagonist, via modeling and simulation analysis in a D2 receptor occupancy study.

Hyeong-Seok Lim et al.PubMed ↗Publisher ↗

No numbers read from the abstract.